Plain-English translation of NCT03908684 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This trial is investigating whether a specialized form of ultrasound imaging—called ultrasound spectroscopy—can predict how well your cancer will respond to radiation therapy early in your treatment. Researchers want to see if certain ultrasound measurements can tell, before traditional scans do, whether the radiation is shrinking your tumor and fighting the cancer effectively. This could help doctors adjust treatment plans faster if needed.
Currently, doctors have to wait weeks or months to see if radiation therapy is actually working by measuring tumor size with standard imaging. This trial exists because finding an earlier, faster way to know if treatment is working could help doctors make better decisions sooner and potentially improve outcomes for cancer patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive your standard radiation therapy as planned, but you will also have additional ultrasound scans performed at different points during your treatment—typically at the beginning, during, and after your course of radiation. These ultrasound scans are non-invasive, painless, and similar to ones you may have had before. Researchers will track how the ultrasound measurements change over time and compare them to how well your tumor responds, helping them understand whether this imaging method can predict treatment success early on.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada